J. Pabst

422 total citations
19 papers, 310 citations indexed

About

J. Pabst is a scholar working on Pharmacology, Pharmacology and Analytical Chemistry. According to data from OpenAlex, J. Pabst has authored 19 papers receiving a total of 310 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pharmacology, 6 papers in Pharmacology and 6 papers in Analytical Chemistry. Recurrent topics in J. Pabst's work include Antibiotics Pharmacokinetics and Efficacy (6 papers), Analytical Methods in Pharmaceuticals (6 papers) and Pharmacogenetics and Drug Metabolism (5 papers). J. Pabst is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (6 papers), Analytical Methods in Pharmaceuticals (6 papers) and Pharmacogenetics and Drug Metabolism (5 papers). J. Pabst collaborates with scholars based in Germany, United States and Norway. J. Pabst's co-authors include G. Leopold, Wilhelm Kirch, E. E. Ohnhaus, H.F. Sailer, Annette I. Garbe, Ingrid Klingmann, Peter H. Hirst, Liv Storstein, Gary R. Pitcairn and Wolfgang Fleischer and has published in prestigious journals such as New England Journal of Medicine, European Heart Journal and American Heart Journal.

In The Last Decade

J. Pabst

16 papers receiving 286 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
J. Pabst Germany	9	136	76	51	49	37	19	310
CR Kumana Hong Kong	11	101 0.7×	58 0.8×	52 1.0×	35 0.7×	45 1.2×	36	354
DJ Sumner United Kingdom	11	138 1.0×	84 1.1×	41 0.8×	23 0.5×	54 1.5×	14	357
Dale A. Raines Saudi Arabia	13	75 0.6×	87 1.1×	35 0.7×	45 0.9×	102 2.8×	25	448
Pekka Ottoila Finland	12	154 1.1×	39 0.5×	92 1.8×	42 0.9×	64 1.7×	19	506
G Betzien Germany	9	107 0.8×	47 0.6×	35 0.7×	19 0.4×	58 1.6×	19	288
Klaus D. Raemsch Germany	6	90 0.7×	71 0.9×	49 1.0×	33 0.7×	54 1.5×	8	376
N. Hockings United Kingdom	8	168 1.2×	27 0.4×	51 1.0×	31 0.6×	40 1.1×	13	341
Karen Fried United States	12	115 0.8×	57 0.8×	69 1.4×	50 1.0×	61 1.6×	15	513
T Douglas Cowart United States	7	108 0.8×	35 0.5×	107 2.1×	22 0.4×	50 1.4×	10	347
JC Petrie United Kingdom	12	189 1.4×	45 0.6×	37 0.7×	17 0.3×	66 1.8×	28	373

Countries citing papers authored by J. Pabst

Since Specialization

Citations

This map shows the geographic impact of J. Pabst's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Pabst with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Pabst more than expected).

Fields of papers citing papers by J. Pabst

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Pabst. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Pabst. The network helps show where J. Pabst may publish in the future.

Co-authorship network of co-authors of J. Pabst

This figure shows the co-authorship network connecting the top 25 collaborators of J. Pabst. A scholar is included among the top collaborators of J. Pabst based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Pabst. J. Pabst is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Vitanova, Keti, et al.. (2017). Reasons for Failure of Systemic-to-Pulmonary Artery Shunts in Neonates. The Thoracic and Cardiovascular Surgeon. 65(S 01). S1–S110.

Pabst, J., et al.. (2008). Digitoxin: pharmakokinetische Befunde bei der Intoxikationsbehandlung mit Colestyramin. DMW - Deutsche Medizinische Wochenschrift. 107(39). 1476–1480.

Kuhlmann, J. & J. Pabst. (2008). Eiweißbindung und Hydroxylierungsrate von Digitoxin bei Niereninsuffizienz. DMW - Deutsche Medizinische Wochenschrift. 107(41). 1551–1555.

Heckmann, M, et al.. (2007). Ein neuer atemzuggesteuerter Pulverinhalator (Auto-Jethaler). Klinische Pädiatrie. 219(2). 66–69. 2 indexed citations

Newman, Stephen P., et al.. (2002). Lung deposition of salbutamol in healthy human subjects from the MAGhaler dry powder inhaler. Respiratory Medicine. 96(12). 1026–1032. 28 indexed citations

Kirch, Wilhelm, et al.. (1989). Digitoxin in patients with hepatorenal insufficiency after repeated oral administration. European Heart Journal. 10(1). 40–47. 2 indexed citations

Kirch, Wilhelm, et al.. (1987). Pharmacokinetics of Bisoprolol During Repeated Oral Administration to Healthy Volunteers and Patients with Kidney or Liver Disease. Clinical Pharmacokinetics. 13(2). 110–117. 51 indexed citations

Leopold, G., et al.. (1986). Pharmacodynamic profile of bisoprolol, a new beta 1‐selective adrenoceptor antagonist.. British Journal of Clinical Pharmacology. 22(3). 293–300. 29 indexed citations

Kirch, Wilhelm, et al.. (1986). Interaction of bisoprolol with cimetidine and rifampicin. European Journal of Clinical Pharmacology. 31(1). 59–62. 31 indexed citations

10.

Kirch, Wilhelm, E. E. Ohnhaus, Piotr Dylewicz, J. Pabst, & Liv Storstein. (1986). Bioavailability and elimination of digitoxin in patients with hepatorenal insufficiency. American Heart Journal. 111(2). 325–329. 15 indexed citations

11.

Pabst, J., et al.. (1986). Basic Pharmacokinetics of Bisoprolol, a New Highly Beta₁‐selective Adrenoceptor Antagonist. The Journal of Clinical Pharmacology. 26(8). 616–621. 69 indexed citations

12.

Wellstein, Anton, et al.. (1985). Concentration Kinetics of Propranolol, Bisoprolol, and Atenolol in Humans Assessed with Chemical Detection and a Subtype-Selective β-Adrenoceptor Assay. Journal of Cardiovascular Pharmacology. 8. S41–S45. 14 indexed citations

13.

Pfannenstiel, P, et al.. (1985). Pharmacokinetics of Bisoprolol and Influence on Serum Thyroid Hormones in Hyperthyroid Patients. Journal of Cardiovascular Pharmacology. 8. S100–S105. 3 indexed citations

14.

Sailer, H.F., et al.. (1985). Pharmacokinetics and Metabolism of Bisoprolol-14C in Three Animal Species and in Humans. Journal of Cardiovascular Pharmacology. 8. S21–S28. 39 indexed citations

15.

Pabst, J., et al.. (1982). Digitoxin accumulation.. British Journal of Clinical Pharmacology. 14(2). 225–229. 7 indexed citations

16.

Ochs, Hermann R., J. Pabst, David J. Greenblatt, & H. J. Dengler. (1980). Noninteraction of Digitoxin and Quinidine. New England Journal of Medicine. 303(12). 672–674. 13 indexed citations

17.

Pabst, J., et al.. (1979). Clinical pharmacology phase I of cefazedone, a new cephalosporin, in healthy volunteers. III. Investigations of the mechanism of renal elimination.. PubMed. 29(2a). 443–8. 2 indexed citations

18.

Eltze, Manfrid, et al.. (1979). [Bioavailability and elimination of various digoxin preparations in the beagle dog and their possible sex dependence (author's transl)].. PubMed. 29(5). 754–7. 3 indexed citations

19.

Pabst, J., et al.. (1979). Clinical pharmacology phase I of cefazedone, a new cephalosporin, in healthy volunteers. II. Pharmacokinetics in comparison with cefazolin.. PubMed. 29(2a). 437–43. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact